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AbstrACt
Objectives In Emilia-Romagna, the Human Papillomavirus 
(HPV) vaccination campaign started in 2008 offering free 
vaccines for 1996 and 1997 cohorts. Systematic active 
invitation was implemented for the 1997 cohort. Our study 
aimed at measuring the impact of the active invitation 
campaign on HPV vaccine coverage and on coverage 
inequalities in 11-year-old girls. Second, we evaluated the 
effect of the HPV vaccination campaign on participation in 
cervical cancer screening by mothers of target girls.
Methods We collected information on vaccination status for 
girls residing in Reggio Emilia in 2008 and mothers’ screening 
history, before and after the 2008 vaccination campaign. 
Log-binomial regression models were performed to estimate 
Relative Risk (RR) and 95% confidence intervals (CIs) of 
being vaccinated as regarded citizenship, siblings, mothers’ 
education, marital status and screening history, stratified by 
birth cohort. We also calculated RR of receiving a Pap test after 
the vaccination campaign as regarded education, daughter’s 
cohort and mothers' decision to have their daughter 
vaccinated. Interaction between education and cohort in 
mothers overdue for Pap testing was calculated.
results Vaccination coverage was 46.3% for the uninvited 
cohort (1046/2260) and 77.9% for the invited cohort 
(1798/2307). In the uninvited cohort, daughters’ vaccination 
showed association with mothers’ education (8 to 11 years of 
education vs. graduated mothers, RR 1.61 95% CI 1.14–2.28), 
citizenship (foreigners vs. Italians, RR 0.45 95% CI 0.37–0.56) 
and screening history (regular vs. non-participant; RR 
1.72 95% CI 1.26–2.36). In the invited cohort, only a slight 
association with screening history persisted (regular vs. non-
participant; RR 1.20 95% CI 1.04–1.40). Highly educated 
under-screened mothers of the invited cohort showed a 
higher probability of receiving a Pap test after the vaccination 
campaign period (RR 1.27 95% CI 1.04–1.56) compared with 
those not invited,
Conclusion Active invitation could increase overall HPV 
immunisation coverage and reduce socio-demographic 
inequalities and the association with mothers' screening 
participation.
IntrOduCtIOn
background
HPV is a necessary cause of cervical cancer1 
and an effective and safe vaccine is now 
available.2 The HPV vaccine has been 
included among the recommended vaccina-
tion schedule in the vast majority of industri-
alised countries. In Italy, it has been included 
among recommended and free vaccines since 
2007 for 11-year-old girls.3
Cervical cancer is an oncologic condi-
tion against which we have developed the 
most effective screening strategy. Pap test 
or HPV test can reduce disease incidence 
by more than 60%, by identification and 
treatment of pre-cancerous lesions.4 Unfor-
tunately, screening strategies need repeated 
testing during a woman’s life and popula-
tion coverage turns out often scarce in many 
countries and regions. On the other hand, 
vaccines used until now only protect women 
from two oncogenic HPV types, which are 
responsible for more than 70% of cancers in 
Europe.5 Thus, vaccinated women will need 
to be screened throughout their lives, even if 
probably less intensively6
Some authors hypothesised that vaccinated 
women might feel completely protected 
strengths and limitations of this study
 ► The peculiar activation of the HPV vaccine campaign 
in the  Emilia-Romagna Region allowed us to 
compare two strategies to offer free vaccine (one 
with active invitation and one without it) with a 
quasi-experimental study design.
 ► We could assess both association between mothers’ 
characteristics and daughters’ vaccine uptake and 
the impact of the vaccination campaign on mothers’ 
participation in screening.
 ► As 11-year-old girls represent the target of 
the  vaccination campaign, for the time being we 
cannot directly assess the impact of vaccination on 
screening participation.
 ► Only data on Pap tests performed through public 
screening programmes were available, while no 
data on opportunistic screening were available.
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therefore considering participation in the screening 
programme as pointless.7 Conversely, other authors 
hypothesised that vaccination campaigns play a sensitisa-
tion role on target women as concerns cervical cancer and 
HPV-related risks, promoting compliance to screening 
protocol.8–12
Many studies tried to disentangle the complex interac-
tions between vaccination and screening campaigns in 
determining women’s behaviour related to vaccine and 
screening uptake, both as individuals and mothers of girls 
in the vaccination target age (figure 1 and figure 2).9 10 13–25
Moreover, screening coverage is often influenced 
by inequalities. Women with low socio-economic status 
or low educational level, immigrant women or stem-
ming from disadvantaged ethnic groups are more often 
under- or never screened.11 12 26 27 In many countries, 
vaccinations have low coverage, therefore outreaching 
strategies such as school-based campaigns and active 
individual invitations are currently being assessed.28 The 
2015 supplements of European Guidelines for Quality 
Assurance in cervical cancer screening reported that 
organised vaccination campaigns, either school-based 
or public health centre-based, are the most effective 
ways to reach the highest vaccination coverage.29 An 
Italian survey showed that regions adopting active invi-
tation by Public Health Authority with fixed appoint-
ment for vaccination and more than one recall for 
non-responders reached wider vaccination coverage.30 
Other studies analysed secondary prevention, leading 
to similar findings. In a 2012 systematic review, active 
invitation with letter led to a higher participation level 
for cervical, breast and colorectal cancer screening 
programmes compared with non-invitation,31 moreover 
organised screening programmes decreased the gradient 
of coverage according to socio-economic status.32
The effect of active invitation on reducing health 
inequalities in HPV vaccination coverage has not yet been 
assessed. Moreover, it is relevant to assess the association 
between non-vaccination and non-participation in the 
screening programme, both potentially related to lack 
of confidence in the National Health Service.33 Indeed, 
vaccination is going to have an impact on cervical cancer 
incidence, in particular when targeting girls at higher risk 
of not being protected by screening in their adulthood.34
The Emilia-Romagna vaccination campaign started 
in 2008 and adopted two different strategies for the 
first two target cohorts. The 1996 cohort, including 
12-year-old girls at that time, was offered free vaccine, 
although without active invitation following an informa-
tion campaign. The 1997 cohort, including 11-year-old 
girls at that time, received active invitation for all girls. 
This different approach gave us an opportunity to eval-
uate the impact of intervention with a quasi-experimental 
study design.
Objective
The primary objective was to measure the impact of 
the active invitation campaign on both HPV vaccine 
coverage in pre-adolescent girls and coverage inequalities 
in Reggio Emilia province.
Our secondary objective was to assess the impact 
of the HPV vaccination campaign on participation in 
cervical cancer screening by mothers of target girls.
MethOds
setting
Reggio Emilia is a province in Emilia-Romagna, an admin-
istrative region of north-east Italy. It has a total popula-
tion of about 550,000. Each 11-year-old cohort comprises 
about 2300 girls.
In Italy, in March 2007, HPV vaccine was included in the 
recommended free vaccine schedule for all 11-year-old 
girls.35
Emilia-Romagna regional council started a vaccination 
campaign in March 2008 (Dgr 236/2008). The 1997 cohort 
was actively invited. In the same period, the Regional 
Health Service also provided free vaccine for girls born in 
1996, although the campaign did not include active invi-
tation. The vaccination campaign included information 
through opportunistic advice from paediatricians and 
information leaflets delivered by Public Health Centres 
for both cohorts and another information document 
about HPV vaccine attached to the invitation letter only 
for the 1997 cohort. Both cohorts maintained the right 
to be vaccinated for free until the age of 18 years. The 
vaccine used was bivalent vaccine Cervarix (GlaxoSmith-
Kline Biologicals) with a three-dose schedule: 0, 1, 6 
months.
Invitation letters for HPV vaccination were delivered 
by the Local Health Authority (LHA) Paediatric Depart-
ment and included demographics, appointment date 
and times, vaccination centre address, information about 
the vaccine, vaccination cycle and vaccination proce-
dure, and contact details when a change of appointment 
was necessary. A leaflet with more detailed information 
on HPV and cervical cancer was attached. In case a girl 
missed her first appointment, two reminders were sent, 
45 days and 90 days from the invitation letter.
Emilia-Romagna has been implementing cervical 
cancer screening since 1999, in compliance with Italian 
Guidelines which recommended 25- to 64-year-old 
women attending cytology-based screening every 3 
years. The entire Reggio Emilia eligible population was 
regularly invited to a fixed appointment, every 3 years. 
The 2008 participation rate was 68%. Test coverage was 
approximately 90%, thanks to spontaneous participation 
in screening and opportunistic private screening.36
study design and population
This is a cohort study based on routinely collected data.
Girls’ cohorts were set up in accordance with the 
Reggio Emilia Health Registry, and included all 
girls living in Reggio Emilia province in 2008 and 
born between 1996 and 1997. Vaccination archives 
collected data on vaccinations by public clinics. 
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By record linkage of the Health Service Popula-
tion Registry and vaccination archives (key: name, 
surname, date of birth) we defined vaccination 
status for each girl, including vaccines adminis-
tered between  2008 and 2011. In Emilia-Romagna, 
vaccinations devoted to 12-year-old individuals were 
run by Public Health clinics, as family paediatricians 
or GPs were not involved in the vaccine administra-
tion. Vaccination registration by the Public Health 
Service was mandatory, all doses being tracked.
Figure 1. Conceptual model for interpreting the relations between vaccination and screening uptake. (A) Possible effects of 
vaccination campaign on screening uptake. Vaccination could influence the future participation in screening in adults receiving 
the vaccine when already eligible for screening but invitation to vaccinate the daughter can act as a reminder for screening 
(left side); the mother’s decision on vaccinating the daughter can also influence the future participation in screening of the 
daughter. (B) Possible association between vaccination and screening history. In this case the preventive attitude of the mother 
influenced her probability of having previously participated in screening, of being vaccinated now or in the future and the choice 
to vaccinate the daughter, but can also influence the preventive attitude of the daughter, thus the propensity of the daughter to 
participate in screening in the future. The red arrows show the relations assessed in the present study.
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Using the Population Registry of Reggio Emilia munic-
ipality, we identified mothers of girls living in Reggio 
Emilia. The Population Registry collects information on 
mothers’ educational level, citizenship, family compo-
sition, and number and order of siblings. Household 
composition for girls resident in other municipalities 
could not be set up, as Population Registries were not 
available. Mothers were also classified in accordance with 
their screening history, by linkage to public screening 
programme archives data37 Supplementary file 1.
Outcomes definition
For our primary objective two outcomes were identified: 
having received at least one dose; and having completed 
the vaccination cycle with three doses within 36 months 
since the vaccination campaign, which started on 8 March 
2008.
For our secondary objective (figure 1A), only mothers 
overdue for a Pap test in 2008 and 2009 were eligible. 
We defined eligible women as follows: mothers who had 
been invited before 1 January 2008 and still non-partic-
ipating at that time (overdue for Pap test on 1 January 
2008) and women who received an invitation letter 
between 2008 and 2009, i.e. who were eligible for the 
organised screening participation between 2008, the 
year of the vaccination campaign, and the following 
2009. For the mothers who were invited for screening in 
2008, we defined the outcome as performing a Pap test 
from 1 January 2008 to 31 March 2009 in the screening 
programme, i.e. during the year of the campaign and 
up to 3 months' later. For mothers invited in 2009, the 
outcome was having a Pap test within 3 months since 
the screening invitation letter. Mothers of girls being 
sisters in different cohorts were excluded.
exposure definition
Birth cohort was the variable defining the intervention: 
active invitation (1997 cohort) and no active invitation 
(1996 cohort). This variable has been used as a determi-
nant of overall coverage and mothers’ participation in 
screening and as effect modifier of the other candidate 
determinants of vaccine coverage.
Girls’ citizenship, mothers' age at birth, education 
level, marital status and number of pregnancies were 
considered as socio-economic candidate determinants. 
Girls’ district of residence was considered as a proxy of 
local health services’ and paediatricians’ attitudes to 
vaccination. Mothers’ participation in cervical cancer 
screening was considered a behavioural candidate 
determinant. According to invitations to cervical cancer 
screening up to 31 December 2007, women were clas-
sified as: non-participant, in case they never took part 
Figure 2. Synthesis of the literature review. (HR: hazard ratio; OR: odds ratio; PR: prevalence ratio; RR: risk ratio; Adj: 
adjusted).
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until 31 December 2008; irregular participant, in case 
they took part in at least one invitation; and regular 
participant, in case they took part in all invitations. 
Variables related to girls' characteristics were available 
for all the province, while variables related to mothers' 
characteristics were available only for the Reggio Emilia 
municipality.
statistical methods
Vaccinated girls percentages (and 95% confidence 
intervals) were calculated for the two cohorts.
We used stratified multivariate log-binomial regres-
sion models, in order to estimate differences in Rela-
tive Risk (RR) and 95% confidence intervals (CIs) of 
 vaccination in the two cohorts. Interaction was calculated 
according to citizenship, educational level, demographics 
(mother’s age at birth, number of pregnancies, marital 
status) and adherence to screening. The effect modifica-
tion was tested using a likelihood ratio test, by comparing 
 the basic model with all covariates and the model with 
all covariates plus the term of interaction between one 
covariate and the cohort.
For the secondary objective, we assessed the RR of 
receiving a Pap test after the vaccination campaign 
in mothers overdue for a Pap test on 1 January 2008, 
by use of a log-binomial regression model adjusted by 
citizenship, mother’s age at birth and education level. 
As regarded this outcome, we also reported models 
stratified by education level. A log-binomial regres-
sion model adjusted by citizenship, mother’s age at 
birth and education level was also performed to assess 
 the RR of receiving a Pap test in mothers, overdue 
for a Pap test on 1 January 2008, who vaccinated or 
did not vaccinate daughters. Only women residing in 
the Reggio Emilia municipality were included.
Data analysis was performed using Stata IC 13. 
In particular, multivariate models were assessed 
thanks to the Generalised Linear Model package using 
link logarithm and family binomial (StataCorp LP, 
College Station, TX, USA).
ethics, funding and data sharing
Our research did not receive any specific grant from 
any public funding agency, commercial companies or 
not-for-profit associations. The Local Ethics Committee 
approved the study protocol on 20 January 2016. 
Record linkage procedures were performed 
in compliance with privacy protection rules. 
Anonymised dataset is available on demand 
 ( paolo. giorgirossi@ ausl. re. it).
results
Impact of the active invitation campaign on hPV vaccine 
coverage in young-adolescent girls
In 2008, Reggio Emilia resident females included 
2260 girls (born in 1996) and 2307 girls (born in 
1997). Examining the 2008 to 2011 archives, we found 
1046 HPV vaccinations (46.3%, 95% CI 44.2–48.4) 
for 1996-born uninvited girls and 1798 vaccinations 
(77.9%, 95% CI 76.2–79.6) for 1997-born actively invited 
girls. Rates of three-doses-vaccinated girls were 43.9% 
(1996 cohort) and 74.9% (1997 cohort).
For both cohorts, vaccination coverage recorded 
a significant gap among six Reggio Emilia districts 
(table 1A, table 2A, Supplementary file 2-table 1A and 
Supplementary file 2-table 2A).
We collected information related to 751 mothers in 
the 1996 cohort, and 769 mothers in the 1997 cohort, 
resident in the Reggio Emilia municipality. Of mothers in 
the screening target age, 99.3% (99.2% for 1996 cohort, 
99.5% for 1997 cohort) have been invited at least once to 
a cervical screening programme before 31 December 2007 
(Supplementary file 1).
Impact of active invitation campaign on hPV vaccine 
inequalities
In the uninvited cohort, Italian girls had a higher rate 
of vaccination (one dose) than foreign ones: 50.0% 
(CI95% 47.7–52.2) versus 22.8% (CI95% 18.2–
27.9) (table 1), RR 0.45 (CI95% 0.37–0.56). In 
the actively invited cohort, there was no differ-
ence in vaccination rate between the two groups 
 (RR 0.97 CI95% 0.92–1.03) (table 2A) 
 (test of interaction: p<0.00005).
Multivariate analysis showed an association 
between levels of mothers’ education and daugh-
ters’ vaccination in the uninvited cohort. Coverage 
in daughters of women with medium education-level 
 (8 to 11 and >12 years of education, non-graduates) was 
higher than coverage in daughters of graduate women 
or with low education level (≤7 years education). In the 
actively invited cohort, no significant difference was found 
among the three higher education levels (table 2B), 
 but the difference might be due to chance 
(test for interaction: p=0.0948).
Moreover, previous participation to cervical cancer 
screening programmes was associated with daughters’ 
vaccination in both cohorts, although association was 
stronger in the uninvited cohort (table 2B and supple-
mentary file 2 -table 2B), also in this case the difference 
between the cohorts can be due to chance (test of inter-
action: p=0.3981).
Considering a thorough vaccination cycle (three doses), the 
results were substantially similar. The only difference was active 
invitation which, compared with no invitation, still reduced 
 the different vaccination coverage between foreign 
girls and Italian ones, although association between 
citizenship and vaccination remained significant 
(supplementary file 2 -table 2A and 
supplementary file 2 -table 2B). 
Impact of hPV vaccination campaign on mothers’ 
participation in cervical cancer screening
Concerning our secondary objective, we anal-
ysed the impact of the vaccination campaign 
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Table 1 Distribution of girls vaccinated with at least one dose of HPV vaccine for girls, services and mothers’ variables 
included in the study, in the two birth cohorts (not invited, 1996; actively invited, 1997). In part a, all girls resident in Reggio 
Emilia were included, while in part b, only girls resident in the municipality of Reggio Emilia were included.
a. Reggio Emilia 
province
Birth cohort 1996 Birth cohort 1997
All Vaccinated (at least one dose) All Vaccinated (at least one dose)
N° N° % N° N° %
All 2260 1046 46.3% 2307 1798 77.9%
Residence
  Correggio 222 84 37.8% 253 188 74.3%
  Montecchio 269 135 50.2% 274 227 82.8%
  Reggio Emilia 999 520 52.1% 989 809 81.8%
  Scandiano 352 98 27.8% 356 202 56.7%
  Castelnuovo Monti 127 70 55.1% 119 109 91.6%
  Guastalla 291 139 47.8% 316 263 83.2%
Citizenship
  Italian 1953 977 50.0% 1975 1535 77.7%
  Foreign 307 70 22.8% 332 264 79.5%
b. Reggio Emilia 
municipality N° N° % N° N° %
All 792 388 49.0% 803 651 81.1%
  Mother identified 715 357 49.9% 730 593 81.2%
  Mother not identified 77 31 40.3% 73 58 79.5%
Mother’s age at birth
  <20 18 6 33.3% 22 18 81.8%
  20–34 605 307 50.7% 584 479 82.0%
  >34 92 44 47.8% 124 96 77.4%
Years of education
  >12, graduate 65 23 35.4% 78 66 84.6%
  >12, non-graduate 261 147 56.3% 280 225 80.4%
  8–11 321 165 51.4% 318 265 83.3%
  ≤7 65 22 33.9% 52 35 67.3%
  Missing 3 0 0.0% 2 2 100.0%
Citizenship
  Italian 609 326 53.5% 608 493 81.1%
  Foreign 106 31 29.2% 122 100 82.0%
Single parent
  Yes 87 44 50.6% 88 74 84.1%
  No 628 313 49.8% 642 519 80.8%
Sibling
  No 161 85 52.8% 162 130 80.2%
  Yes 554 272 49.1% 568 463 81.5%
Screening history
  Non-participant 89 29 32.6% 90 62 68.9%
  Irregular participant 335 164 49.0% 341 283 83.0%
  Regular participant 285 162 56.8% 295 245 83.1%
  Missing 6 2 33.3% 4 3 75.0%
 o
n
 14 August 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-016189 on 25 September 2017. Downloaded from 
 7Venturelli F, et al. BMJ Open 2017;7:e016189. doi:10.1136/bmjopen-2017-016189
Open Access
exposure on participation in organised screening by 
mothers overdue for a Pap test on 1 January 2008. 
 No overall differences in participation were 
recorded in the two cohorts. Mothers who had 
their daughters vaccinated at least with one dose, 
recorded higher participation if compared with 
mothers who didn’t have their daughters vaccinated 
 (73.1% and 61.5% respectively, RR 1.18 95% CI 
1.07–1.30) (table 3). Similar results were found 
in a thorough immunisation cycle (supplemen-
tary file 2 -table 3). Furthermore, by stratifying 
mothers according to their educational level, 
we observed that graduate mothers of actively 
invited girls showed a stronger likelihood of 
participating in screening programmes after 
the vaccination campaign period, if compared 
Table 2 Relative risk (RR) of being vaccinated with at least one dose for girls in the two birth cohorts (not invited, 1996; 
actively invited, 1997). Multivariate log-binomial regression models stratified by birth cohort and adjusted by citizenship, 
educational level, demographics (mother’s age at birth, number of pregnancies, marital status) and adherence to screening 
were performed. In part a, all girls resident in Reggio Emilia were included while in part b, only girls resident in the municipality 
of Reggio Emilia were included.
a. Reggio Emilia province
Birth cohort 1996 (n=2260) Birth cohort 1997 (n=2307)
Vaccinated (at least one 
dose) Vaccinated (at least one dose)
RR 95% CI RR 95% CI
Residence (test for interaction p=0.1005)
  Correggio 1 – 1 –
  Montecchio 1.26 (1.03 to 1.55) 1.12 (1.02 to 1.22)
  Reggio Emilia 1.35 (1.14 to 1.61) 1.10 (1.02 to 1.19)
  Scandiano 0.71 (0.56 to 0.90) 0.76 (0.68 to 0.86)
  Castelnuovo Monti 1.42 (1.13 to 1.78) 1.24 (1.13 to 1.35)
  Guastalla 1.25 (1.03 to 1.54) 1.12 (1.03 to 1.23)
Citizenship (test for interaction p<0.00005)
  Italian 1 – 1 –
  Foreign 0.45 (0.37 to 0.56) 0.97 (0.92 to 1.03)
b. Reggio Emilia municipality (n=706) (n=724)
Mother’s age at birth
(test for interaction p=0.5382)
  <20 1 – 1 –
  20–34 1.26 (0.67 to 2.38) 0.98 (0.78 to 1.22)
  >34 1.28 (0.66 to 2.48) 0.93 (0.73 to 1.18)
Years of education
(test for interaction p=0.0948)
  >12, graduate 1 – 1 –
  >12, non-graduate 1.55 (1.10 to 2.19) 0.95 (0.85 to 1.06)
  8–11 1.61 (1.14 to 2.28) 0.98 (0.88 to 1.10)
  ≤7 1.06 (0.66-1-69) 0.82 (0.66 to 1.01)
Single parent (test for interaction p=0.4809)
  No 1 – 1 –
  Yes 1.06 (0.86 to 1.31) 1.08 (0.98 to 1.19)
Sibling (test for interaction p=0.5543)
  No 1 – 1 –
  Yes 0.99 (0.83 to 1.16) 1.04 (0.95 to 1.14)
Screening history (test for interaction p=0.3981)
  Non-participant 1 – 1 –
  Irregular participant 1.49 (1.09 to 2.04) 1.19 (1.03 to 1.38)
  Regular participant 1.72 (1.26 to 2.36) 1.20 (1.04 to 1.40)
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with those of the uninvited cohort (table 3). 
No difference was found in screening participation 
between the two cohorts, when stratifying mothers 
according to daughter’s vaccination (test of interaction: 
p=0.730 for vaccination with at least one dose, p=0.581 
with three doses).
dIsCussIOn
Two birth cohorts were simultaneously exposed to 
two different vaccination strategies. The actively 
invited cohort recorded higher immunisation uptake 
and reduced socio-economic inequalities, compared 
with the not actively invited cohort. Active invitation 
considerably decreased inequalities due to immigra-
tion status and educational level and it less markedly 
reduced association with mother’s participation in 
screening, although it had almost no impact geograph-
ically (ie, increase was almost the same for all districts). 
Moreover, the active invitation for daughters’ vacci-
nation acted as a reminder for mothers overdue 
for cervical cancer screening, but only among 
women graduates.
Table 3 Relative risk (RR) of receiving a Pap test after the vaccination campaign in mothers overdue for a Pap test on 
1 January 2008. Two log-binomial regression models adjusted by mother’s age at birth, education level and citizenship was 
performed: the first to test the effect of the active vaccination campaign (1997 cohort) versus no invitation (1996 cohort) 
and the second to test the association between daughter’s vaccination. Second, the RR of receiving a Pap test after the 
vaccination campaign among mother’s education strata was assessed performing a stratified log-binomial regression model 
adjusted by mother’s age at birth and citizenship. Only women resident in the Reggio Emilia municipality were included. 
[Low ≤11 years of education; Medium >12, non-graduate; High >12, graduate]
Mothers overdue for a Pap test on 1 January 2008
Pap test participation
(%) RR 95% CI
Mother’s age at birth
  <20 (n=4) 50.0 1 –
  20–34 (n=736) 70.7 1.26 (0.47 to 3.36)
  >34 (n=213) 64.8 0.75 (0.42 to 3.02)
Years of education
  >12, graduate (n=101) 81.2 1 –
  >12, non-graduate (n=345) 75.4 0.91 (0.81 to 1.02)
  ≤12 (n=505) 62.6 0.76 (0.67 to 0.85)
Citizenship
  Italian (n=815) 69.7 1 –
  Foreign (n=138) 66.7 0.99 (0.87 to 1.13)
Cohort
  1996 (n=472) 68.0 1 –
  1997 (n=481) 70.5 1.04 (0.96 to 1.13)
Daughter’s vaccination status (at least one dose)
  Mothers who did not vaccinate (n=317) 61.5 1 –
  Mothers who vaccinated
  (n=636)
73.1 1.18 (1.07 to 1.30)
Stratified analyses
by mother’s educational level (test for interaction p=0.0402)
Low (n=505)
  1996 62.1 1 – 
  1997 63.1 1.01 (0.88 to 1.16)
Medium (n=345)
  1996 75.9 1 –
  1997 74.3 0.98 (0.86 to 1.11)
High (n=95)
  1996 69.8 1 –
  1997 89.7 1.27 (1.04 to 1.56)
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Our work is one of the few Italian studies which 
compares immunisation coverage between vaccination 
strategies with and without active invitation. Our results 
are consistent with those reached by Giambi et al's30 study 
and a previous systematic review,31 although considering 
secondary prevention programmes.
The association between HPV vaccination and cervical 
cancer screening participation gets high relevance in a 
public health perspective for two main reasons. First, it 
sharply reduces the effectiveness of intervention on the 
burden of disease. As a matter of fact, the vast majority 
of invasive cervical cancers occurring in industrialised 
countries are now affecting under-screened women. 
Therefore, failing to vaccinate them would almost reduce 
the impact of vaccination in a public health perspective. 
Second, vaccination could play either a positive or nega-
tive role in screening participation for mothers of vaccine 
target cohorts and young adult women who are them-
selves the target of opportunistic vaccination.
In order to further analyse such connections, several 
study designs have been adopted, as shown by figure 2. 
Some authors stressed the association between vaccina-
tion in young adult women and screening habits. We 
defined this as the ‘mothers on mothers’ effect. Unfor-
tunately, such studies, cannot yet be performed on 
cohorts that have been targeted by mass vaccination 
campaigns.9 10 13–16 Other authors described the associa-
tion between mothers’ screening habits and daughters’ 
vaccination, suggesting that a preventive attitude by 
mothers would determine their daughters’ attitude, once 
they have reached screening target age. We defined it as 
the ‘mothers on daughters’ effect.17–24 Finally, some other 
studies observed the impact of the vaccination campaign 
on mothers’ screening habits. We defined it as the ‘daugh-
ters on mothers’ effect.25
Vaccination and socio-demographic characteristics
In the uninvited cohort of Reggio Emilia province 
resident girls, a lower immunisation coverage among 
foreigners was recorded in comparison to Italians. 
Moreover, mothers at the lowest and highest education 
level were less likely to have their daughters vaccinated, 
in comparison to mothers at medium education level. 
Despite vaccine being free, our results were consistent 
with several other studies reporting girls from ethnic 
minorities and more deprived areas showing lower 
complete immunisation series in comparison to more 
advantaged girls.12 38–46 On the contrary, in the actively 
invited cohort we found no difference in one-dose vacci-
nation, either considering citizenship or education level. 
Taking into account the thorough immunisation cycle, 
foreign mothers still vaccinate to a lesser extent, when 
compared with Italian mothers, as less educated mothers 
do in comparison to graduate mothers, but with a signifi-
cantly reduced gap. A Canadian population-based study 
showed that school-based vaccination programmes can 
lead to high vaccination coverage even in areas populated 
by a higher proportion of ethnic minorities.47
Vaccination and mother’s participation in screening
A recent review reported an association between high 
HPV vaccination and ethnic majority populations, high 
socio-economic status, as well as mother’s preventive 
attitude assessed through cervical screening participa-
tion and previous vaccination during childhood.46 The 
relationship between HPV vaccination and cervical 
cancer screening participation was thoroughly discussed. 
Recently, many studies reported a positive association 
between HPV vaccination history and attendance of 
cervical cancer screening (figure 2).9 10 13–16 39
We could not assess screening uptake in vaccinated 
and non-vaccinated girls, because cohorts targeted 
by the vaccination campaign were still too young for 
screening. Therefore, just like many previous studies 
did,17–24 we considered an association between mothers’ 
participation history in cervical screening programmes as 
a proxy of future attitudes to screening of girls (figure 1B). 
Our findings were consistent with recent studies,17–24 
showing that immunisation coverage in daughters of 
mothers regularly and irregularly participating in cervical 
cancer screening was higher than immunisation coverage 
in daughters of non-participating women.
Evidence of an impact of parental attitudes towards 
preventive measures in daughters’ decision-making was 
widely reported.23 24 48 49 A qualitative systematic review 
described girls as mainly ‘HPV vaccine passive recipients’ 
and stressed the role of parents affected by concerns 
about the safety/efficacy of vaccines and sexual mores.50 
Our study showed an active invitation strategy be less 
effective in reducing differences related to mother’s 
preventive behaviours, than socio-demographic inequali-
ties. Nevertheless, increasing overall vaccination coverage 
directly reduced the absolute values of non-vaccinated 
girls in both groups.
Active invitation campaign – ‘daughter on mother’ effect
Concerning our secondary objective we analysed whether 
exposure to the active invitation campaign could increase 
mother’s participation in cervical cancer screening 
(figure 1A). We recorded no difference in Pap test 
participation after the campaign period between overall 
previous non-participant mothers related to the two 
birth cohorts. In addition, although daughters’ vaccina-
tions were associated with higher screening participa-
tion, difference turned out almost the same in the two 
cohorts. Nevertheless, stratifying by educational level 
we could observe an effect of vaccination active invita-
tion on mother’s screening participation only among 
graduate mothers overdue for a Pap test. A new British 
study recorded an increased screening participation 
among mothers exposed to an active national vaccina-
tion programme.25 The different impact of receiving an 
invitation letter for daughter’s vaccination in graduated 
mothers and non-graduated ones might be connected 
to how the link between HPV vaccination and cervical 
cancer screening was illustrated by both invitation letter 
and information leaflet. In particular, the Reggio Emilia 
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LHA invitation letter gave brief information about HPV 
vaccine preventing cervical cancer, while a short indica-
tion of the necessity of screening by vaccinated women 
was only reported in a separate leaflet. The correlation 
between vaccine and screening probably required a 
higher level of health literacy. An invitation letter, which 
more clearly explained primary and secondary cervical 
cancer prevention programmes and written in different 
languages, should be considered to further test its possible 
impact on the screening awareness and participation, also 
by disadvantaged population groups.
strengths and limitations
Availability of data exclusively related to LHA-organised 
screening represents the major limitation of our study.
Although 75% total screening coverage was represented, 
which is a much higher level than the average Italian one, 
a significant part of Pap tests was not included.27
Moreover, only cohorts residing in one province and 
because of screening association/effect residing in one 
municipality were included, thus limiting both eligibility 
of subjects and generalisability of results.
The quasi-experimental comparison of two vaccination 
strategies in a cohort study design and the use of routinely 
collected data are to be mentioned as our strength. They 
allowed us to assess the real participation of mothers 
and daughters in primary and secondary prevention 
programmes, which is a more reliable value than a self-re-
ported willingness to participate.
COnClusIOns
According to our study, active invitation was effective 
in increasing overall HPV immunisation coverage and 
reducing both socio-demographic inequalities and 
association with mother’s preventive behaviours. The 
impact of the vaccination campaign as a reminder 
for mothers’ screening was only detectable in highly 
educated women.
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